Evidence map›Paper›PMID 32370092›Full record

ReviewInternational journal of molecular sciences2020

Safeguarding Female Reproductive Health against Endocrine Disrupting Chemicals-The FREIA Project.

Majorie B M van Duursen, Julie Boberg, Sofie Christiansen, Lisa Connolly, Pauliina Damdimopoulou, Panagiotis Filis, Paul A Fowler, Bart M Gadella, Jan Holte, Kersti Jääger and 11 more

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Knowledge and attitudes of pregnant women about endocrine disruptors.Revista da Associacao Medica Brasileira (1992) · 2025
    Article
  8. Article
  9. Screening for toxicity of azole fungicides inmicroPublication biology · 2025
    Article
  10. EndoCompass Project: Environmental Endocrinology.Hormone research in paediatrics · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. The profile of steroid hormones in human fetal and adult ovaries.Reproductive biology and endocrinology : RB&E · 2024
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 12 institutions in 8 countries.

Majorie B M van DuursenDepartment Environment and Health, Vrije Universiteit Amsterdam, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands.ORCID 0000-0002-3838-9731
Julie BobergNational Food Institute, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.
Sofie ChristiansenNational Food Institute, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.
Lisa ConnollyThe Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, BT9 5DL Belfast, Northern Ireland, UK.
Pauliina DamdimopoulouDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, SE-14186 Stockholm, Sweden.
Panagiotis FilisInstitute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, Foresterhill, AB23 8ZD Aberdeen, UK.
Paul A FowlerInstitute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, Foresterhill, AB23 8ZD Aberdeen, UK.
Bart M GadellaDepartment of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 2, 3584 CM Utrecht, The Netherlands.
Jan HolteCarl von Linné Clinic, Uppsala Science Park, S-751 83 Uppsala, Sweden.
Kersti JäägerDepartment of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu and Competence Centre on Health Technologies, Teaduspargi 13, 50411 Tartu, Estonia.
Hanna K L JohanssonNational Food Institute, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.
Tianyi LiDivision of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet and Karolinska University Hospital, SE-14186 Stockholm, Sweden.
Séverine Mazaud-GuittotUniv Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, F-35000 Rennes, France.
Anne-Simone ParentNeuroendocrinology Unit, GIGA-Institute, University of Liège, Belgium.1, Avenue de l'hôpital, 4000 Liège, Belgium.
Andres SalumetsDepartment of Obstetrics and Gynaecology, Institute of Clinical Medicine, University of Tartu and Competence Centre on Health Technologies, Teaduspargi 13, 50411 Tartu, Estonia.ORCID 0000-0002-1251-8160
Ana M SotoDepartment of Immunology, Tufts University School of Medicine, Boston, MA0211, USA.
Terje SvingenNational Food Institute, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.ORCID 0000-0003-4650-7651
Agne Velthut-MeikasDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, 12618 Tallinn, Estonia.ORCID 0000-0003-1927-9016
Eva Bay WedebyeNational Food Institute, Technical University of Denmark, DK-2800 Kongens Lyngby, Denmark.
Yuling XieThe Institute for Global Food Security, School of Biological Sciences, Queen's University Belfast, BT9 5DL Belfast, Northern Ireland, UK.
Martin van den BergDepartment of Population Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Yalelaan 2, 3584 CM Utrecht, The Netherlands.
Technical University of Denmark · DKCompetence Centre on Health Technologies (Estonia) · EEKarolinska University Hospital · SEQueen's University Belfast · GBUniversity of Aberdeen · GBUtrecht University · NLCarl von Linné Clinic · SEInserm · FRTallinn University of Technology · EETufts University · USUniversity of Liège · BEVrije Universiteit Amsterdam · NL

Funding

Horizon 2020 825100
6 · The paper itself

Abstract

Currently available test methods are not well-suited for the identification of chemicals that disturb hormonal processes involved in female reproductive development and function. This renders women's reproductive health at increasing risk globally, which, coupled with increasing incidence rates of reproductive disorders, is of great concern. A woman's reproductive health is largely established during embryonic and fetal development and subsequently matures during puberty. The endocrine system influences development, maturation, and function of the female reproductive system, thereby making appropriate hormone levels imperative for correct functioning of reproductive processes. It is concerning that the effects of human-made chemicals on the endocrine system and female reproductive health are poorly addressed in regulatory chemical safety assessment, partly because adequate test methods are lacking. Our EU-funded project FREIA aims to address this need by increasing understanding of how endocrine disrupting chemicals (EDCs) can impact female reproductive health. We will use this information to provide better test methods that enable fit-for-purpose chemical regulation and then share our knowledge, promote a sustainable society, and improve the reproductive health of women globally.

Indexed as

Reproductive HealthAnimalsEndocrine DisruptorsEndocrine SystemEnvironmental ExposureEnvironmental PollutantsFemaleHumansPubertyReproductionRisk AssessmentRisk FactorsEndocrine DisruptorsEnvironmental Pollutantsadrenalbioassayendocrine disrupting chemicalsfemale reproductive healthfertilitymammary glandoocyteovaryrisk assessmentsteroidogenesistest methods

Identifiers

PMID32370092
PMCPMC7246859
OpenAlexW3023547254

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.